Literature DB >> 22553727

Retinal stem cells transplantation combined with copolymer-1 immunization reduces interferon-gamma levels in an experimental model of glaucoma.

Xia Zhou1, Xiao-Bo Xia.   

Abstract

AIM: To explore the effect of immunization with copolymer-1 (COP-1) and retinal stem cells (RSCs) transplantation on interferon-gamma (IFN-γ) levels in a rat experimental glaucoma model.
METHODS: An experimental glaucoma was induced by argon laser photocoagulation of the episcleral veins and limbal plexus in the right eye of rats. Immediately following glaucoma induction, rats were immunized with COP-1. RSCs were cultured and transplanted intravitreally into the eyes of glaucoma model animals 1 week post-laser treatment. Six experimental groups were used: COP-1/RSC, PBS/RSC, COP-1/PBS, PBS/PBS, glaucoma model group, and a normal control group. The concentration of IFN-γ in aqueous humor (AH) and serum was measured by enzyme-linked immunosorbent assay (ELISA) in each of the six groups. Retinal ganglion cell (RGC) survival was assessed by quantifying apoptosis using Hoechst staining.
RESULTS: Concentrations of IFN-γ in AH and serum of rats that had undergone glaucoma induction were higher than those of non-induced control rats. The concentrations of IFN-γ in AH and serum of the COP-1/RSCs treated group were determined to be 2371.9ng/L and 710.9ng/L, respectively, which were significantly lower than those in the other treated groups (P<0.05). In fact, IFN-γ levels in the dual treated group were reduced to background levels. The COP-1/RSC group had lower number of apoptotic RGCs than the other three experimental groups (P<0.05).
CONCLUSION: The reduced levels of IFN-γ in AH and serum of the COP-1/RSC group may be related to synergistic effects between RSCs transplantation and COP-1 immune modulation. It is likely that the lower levels of IFN-γ prevented RGCs glaucomatous apoptosis.

Entities:  

Keywords:  COP-1 immunization; RSC transplantation; glaucoma; interferon-gamma

Year:  2011        PMID: 22553727      PMCID: PMC3340800          DOI: 10.3980/j.issn.2222-3959.2011.06.04

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  26 in total

1.  Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells.

Authors:  Oleg Butovsky; Yaniv Ziv; Adi Schwartz; Gennady Landa; Adolfo E Talpalar; Stefano Pluchino; Gianvito Martino; Michal Schwartz
Journal:  Mol Cell Neurosci       Date:  2005-11-16       Impact factor: 4.314

2.  GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells.

Authors:  Yusuke Tozuka; Satoshi Fukuda; Takashi Namba; Tatsunori Seki; Tatsuhiro Hisatsune
Journal:  Neuron       Date:  2005-09-15       Impact factor: 17.173

3.  Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers.

Authors:  Oleg Butovsky; Shay Bukshpan; Gilad Kunis; Steffen Jung; Michal Schwartz
Journal:  Mol Cell Neurosci       Date:  2007-05-01       Impact factor: 4.314

Review 4.  Neuroprotection in glaucoma: recent and future directions.

Authors:  Helen V Danesh-Meyer
Journal:  Curr Opin Ophthalmol       Date:  2011-03       Impact factor: 3.761

5.  Effects of bone marrow stromal cell injection in an experimental glaucoma model.

Authors:  Saiyuu Yu; Teruyo Tanabe; Mari Dezawa; Hiroto Ishikawa; Nagahisa Yoshimura
Journal:  Biochem Biophys Res Commun       Date:  2006-04-27       Impact factor: 3.575

Review 6.  The immune response in glaucoma: a perspective on the roles of oxidative stress.

Authors:  Gülgün Tezel
Journal:  Exp Eye Res       Date:  2010-08-13       Impact factor: 3.467

7.  Laser-induced chronic ocular hypertension model on SD rats.

Authors:  Kin Chiu; Raymond Chang; Kwok-Fai So
Journal:  J Vis Exp       Date:  2007-12-04       Impact factor: 1.355

8.  TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.

Authors:  Ahjoku Amadi-Obi; Cheng-Rong Yu; Xuebin Liu; Rashid M Mahdi; Grace Levy Clarke; Robert B Nussenblatt; Igal Gery; Yun Sang Lee; Charles E Egwuagu
Journal:  Nat Med       Date:  2007-05-13       Impact factor: 53.440

Review 9.  Post-ischemic brain damage: pathophysiology and role of inflammatory mediators.

Authors:  Diana Amantea; Giuseppe Nappi; Giorgio Bernardi; Giacinto Bagetta; Maria T Corasaniti
Journal:  FEBS J       Date:  2009-01       Impact factor: 5.542

Review 10.  Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection.

Authors:  Martin B Wax; Gülgün Tezel
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

View more
  4 in total

1.  The effects of intravitreal H2 S application on apoptosis in the retina and cornea in experimental glaucoma model.

Authors:  Zuleyha Erisgin; Murat Atabey Ozer; Murat Tosun; Serkan Ozen; Selcuk Takir
Journal:  Int J Exp Pathol       Date:  2019-11-27       Impact factor: 1.925

2.  T-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucoma.

Authors:  ManSin Wong; Ping Huang; Weiyi Li; Ying Li; Samuel S Zhang; Chun Zhang
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 3.  The promise of stem cell-based therapeutics in ophthalmology.

Authors:  Israel Aharony; Shalom Michowiz; Nitza Goldenberg-Cohen
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

Review 4.  T Cell-Mediated Autoimmunity in Glaucoma Neurodegeneration.

Authors:  Lixiang Wang; Xin Wei
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.